Search results
Results from the WOW.Com Content Network
Canine cancer detection is an approach to cancer screening that relies upon the claimed olfactory ability of dogs to detect, in urine or in breath, very low concentrations of the alkanes and aromatic compounds generated by malignant tumors. While some research has been promising, no verified studies by secondary research groups have ...
Chlortalidone is considered a first-line medication for treatment of high blood pressure. [2] Some recommend chlortalidone over hydrochlorothiazide. [1] [15] A meta-analysis of randomized controlled trials found that chlortalidone is more effective than hydrochlorothiazide for lowering blood pressure, while the two drugs have similar toxicity.
Mast cell tumor on lip of a dog. Veterinary oncology is a subspecialty of veterinary medicine that deals with cancer diagnosis and treatment in animals. Cancer is a major cause of death in pet animals. In one study, 45% of the dogs that reached 10 years of age or older died of cancer. [1]
“But probiotics have numerous benefits for dogs in a variety of situations, especially overall immune health because more than 70% of your dog’s immune system is in their gastrointestinal ...
Current cure rates using stem cell therapy in dogs approximates that achieved in humans, 40-50%. When cost is a factor, prednisone used alone can improve the symptoms dramatically, but it does not significantly affect the survival rate. The average survival times of dogs treated with prednisone and untreated dogs are both one to two months. [1]
Nonlymphomatous stomach cancer is usually an adenocarcinoma, and nonlymphomatous intestinal cancer is usually polyps, adenomas, adenocarcinomas, leiomyosarcomas, and leiomyomas. [165] Kidney cancer* is uncommon in dogs. The most common type is renal cell carcinoma. [165] Lung cancer* is usually the result of metastasis in dogs. Primary tumors ...
For premium support please call: 800-290-4726 more ways to reach us
Maropitant (INN; [3] brand name: Cerenia, used as maropitant citrate , is a neurokinin-1 (NK 1) receptor antagonist developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs. It was approved by the FDA in 2007, for use in dogs [4] [5] and in 2012, for cats. [6]